Invesco’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Buy |
106,863
+25,735
| +32% | +$99.6K | ﹤0.01% | 3244 |
|
|
2025
Q1 | $406K | Sell |
81,128
-165,958
| -67% | -$830K | ﹤0.01% | 3227 |
|
|
2024
Q4 | $1.78M | Buy |
247,086
+215,375
| +679% | +$1.55M | ﹤0.01% | 2651 |
|
|
2024
Q3 | $195K | Buy |
31,711
+968
| +3% | +$5.94K | ﹤0.01% | 3509 |
|
|
2024
Q2 | $204K | Buy |
30,743
+2,986
| +11% | +$19.9K | ﹤0.01% | 3603 |
|
|
2024
Q1 | $283K | Sell |
27,757
-718,424
| -96% | -$7.31M | ﹤0.01% | 3533 |
|
|
2023
Q4 | $8.39M | Buy |
746,181
+713,152
| +2,159% | +$8.02M | ﹤0.01% | 1928 |
|
|
2023
Q3 | $85.9K | Buy |
33,029
+4,956
| +18% | +$12.9K | ﹤0.01% | 3725 |
|
|
2023
Q2 | $99.1K | Buy |
+28,073
| New | +$99.1K | ﹤0.01% | 3713 |
|
|
2023
Q1 | – | Sell |
-425,849
| Closed | -$7.01M | – | 3849 |
|
|
2022
Q4 | $7.01M | Buy |
+425,849
| New | +$7.01M | ﹤0.01% | 2064 |
|
|
2022
Q2 | – | Sell |
-12,318
| Closed | -$75K | – | 4005 |
|
|
2022
Q1 | $75K | Buy |
12,318
+487
| +4% | +$2.97K | ﹤0.01% | 3853 |
|
|
2021
Q4 | $108K | Sell |
11,831
-1,109
| -9% | -$10.1K | ﹤0.01% | 3855 |
|
|
2021
Q3 | $147K | Buy |
12,940
+2,502
| +24% | +$28.4K | ﹤0.01% | 3836 |
|
|
2021
Q2 | $103K | Sell |
10,438
-402,385
| -97% | -$3.97M | ﹤0.01% | 3860 |
|
|
2021
Q1 | $5.83M | Sell |
412,823
-292,575
| -41% | -$4.13M | ﹤0.01% | 2290 |
|
|
2020
Q4 | $7.96M | Buy |
705,398
+269,439
| +62% | +$3.04M | ﹤0.01% | 1924 |
|
|
2020
Q3 | $5.75M | Buy |
435,959
+206,300
| +90% | +$2.72M | ﹤0.01% | 1939 |
|
|
2020
Q2 | $2.46M | Buy |
+229,659
| New | +$2.46M | ﹤0.01% | 2372 |
|
|
2017
Q1 | – | Sell |
-329
| Closed | -$320K | – | 3692 |
|
|
2016
Q4 | $320K | Buy |
+329
| New | +$320K | ﹤0.01% | 3435 |
|